Suppr超能文献

正常及功能受损肾脏对碘化造影剂的微血管阻力

Microvascular resistance in response to iodinated contrast media in normal and functionally impaired kidneys.

作者信息

Kurihara Osamu, Takano Masamichi, Uchiyama Saori, Fukuizumi Isamu, Shimura Tetsuro, Matsushita Masato, Komiyama Hidenori, Inami Toru, Murakami Daisuke, Munakata Ryo, Ohba Takayoshi, Hata Noritake, Seino Yoshihiko, Shimizu Wataru

机构信息

Cardiovascular Centre, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

出版信息

Clin Exp Pharmacol Physiol. 2015 Dec;42(12):1245-50. doi: 10.1111/1440-1681.12479.

Abstract

Contrast-induced nephropathy (CIN) is considered to result from intrarenal vasoconstriction, and occurs more frequently in impaired than in normal kidneys. It was hypothesized that iodinated contrast media would markedly change renal blood flow and vascular resistance in functionally impaired kidneys. Thirty-six patients were enrolled (32 men; mean age, 75.3 ± 7.6 years) undergoing diagnostic coronary angiography and were divided into two groups based on the presence of chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (eGFR) of < 60 mL/min per 1.73 m(2) (CKD and non-CKD groups, n = 18 in both). Average peak velocity (APV) and renal artery resistance index (RI) were measured by Doppler flow wire before and after administration of the iodinated contrast media. The APV and the RI were positively and inversely correlated with the eGFR at baseline, respectively (APV, R = 0.545, P = 0.001; RI, R = -0.627, P < 0.001). Mean RI was significantly higher (P = 0.015) and APV was significantly lower (P = 0.026) in the CKD than in the non-CKD group. Both APV (P < 0.001) and RI (P = 0.002) were significantly changed following contrast media administration in the non-CKD group, but not in the CKD group (APV, P = 0.258; RI, P = 0.707). Although renal arterial resistance was higher in patients with CKD, it was not affected by contrast media administration, suggesting that patients with CKD could have an attenuated response to contrast media.

摘要

对比剂肾病(CIN)被认为是由肾内血管收缩引起的,在肾功能受损的肾脏中比正常肾脏更常见。据推测,碘化造影剂会显著改变功能受损肾脏的肾血流量和血管阻力。36例接受诊断性冠状动脉造影的患者(32例男性;平均年龄75.3±7.6岁)根据慢性肾脏病(CKD)的存在情况分为两组,CKD定义为估算肾小球滤过率(eGFR)<60ml/(min·1.73m²)(CKD组和非CKD组,每组n = 18)。在给予碘化造影剂之前和之后,通过多普勒血流导线测量平均峰值流速(APV)和肾动脉阻力指数(RI)。APV和RI在基线时分别与eGFR呈正相关和负相关(APV,R = 0.545,P = 0.001;RI,R = -0.627,P < 0.001)。CKD组的平均RI显著更高(P = 0.015),APV显著更低(P = 0.026)。在非CKD组中,给予造影剂后APV(P < 0.001)和RI(P = 0.002)均有显著变化,但在CKD组中没有(APV,P = 0.258;RI,P = 0.707)。尽管CKD患者的肾动脉阻力更高,但不受造影剂给药的影响,这表明CKD患者对造影剂的反应可能减弱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/5063113/e6b103a58e7b/CEP-42-1245-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验